Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

6(75.0%)

Phase 2

1(12.5%)

Phase 1

1(12.5%)

8Total

N/A(6)

Phase 2(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT03564730Not ApplicableActive Not Recruiting

Staged Versus Simultaneous Bilateral Knee Arthroplasty

Role: lead

NCT06696313Not ApplicableActive Not Recruiting

Radiographic Migration Analysis of the Insignia Hip Stem

Role: collaborator

NCT06942624Phase 1Not Yet Recruiting

Phage Therapy for the Treatment of a Chronic Enterococcus Faecium Periprosthetic Joint Infection

Role: lead

NCT04541693Not ApplicableActive Not Recruiting

REDAPT Revision Hip System With RSA

Role: lead

NCT03554720Not ApplicableCompleted

RSA of the ATTUNE Knee System: RCT Comparing Traditional Vs Enhanced-Fixation Device Designs

Role: collaborator

NCT03416946Not ApplicableCompleted

Custom Cutting Block Instrument vs Regular Instrumentation Total Knee Replacement (TKR)

Role: lead

NCT04649424Not ApplicableCompleted

COVID-19 Nasal Swab Trial

Role: lead

NCT02393963Phase 2Completed

Intra-articular Tranexamic Acid in the Reduction of Blood Transfusions in Primary Total Hip and Total Knee Arthroplasty

Role: lead

All 8 trials loaded